Chlorin E6: a Promising Photosensitizer of Anti-tumor and Anti-inflammatory Effects in PDT

Overview

Journal Nanomedicine (Lond)

Date 2025 Jan 29

PMID 39877963

Authors

Hairong Yu

Ziling Huang

Jiale Wu

Ziming Zhao

Yabing Hua

Yihua Yang

Affiliations

Soon will be listed here.

Abstract

Photodynamic therapy (PDT) involves the activation of photosensitizers (PSs) by visible laser light at the target site to catalyze the production of reactive oxygen species, resulting in tumor cell death and blood vessel closure. The efficacy of PDT depends on the PSs, the amount of oxygen, and the intensity of the excitation laser. PSs have been extensively researched, and great efforts have been made to develop an ideal photosensitizer. Chlorin-e6 is an FDA-approved second-generation PSs that has attracted widespread research interest in the medical field, especially with respect to antitumor and anti-inflammatory activity. Chlorin-e6 possesses the advantages of a large absorption coefficient, high strength, low residue in the body, and relatively high safety and thus has promising application prospects. Here we review the use of chlorin-e6 in PDT and discuss the prospects of further development of this technology.

References

Zuo Q, Lyu J, Shen X, Wang F, Xing L, Zhou M . A Less-is-More Strategy for Mitochondria-Targeted Photodynamic Therapy of Rheumatoid Arthritis. Small. 2024; 20(25):e2307261. DOI: 10.1002/smll.202307261. View

Thiery J, Chopin D . Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 1999; 18(1):31-42. DOI: 10.1023/a:1006256219004. View

Kook M, Lee C, Jeong Y, Kim B . Nanophotosensitizers for Folate Receptor-Targeted and Redox-Sensitive Delivery of Chlorin E6 against Cancer Cells. Materials (Basel). 2020; 13(12). PMC: 7344700. DOI: 10.3390/ma13122810. View

Liu W, Ma X, Jin Y, Zhang J, Li Y, Tang Y . Chlorin e6-Biotin Conjugates for Tumor-Targeting Photodynamic Therapy. Molecules. 2021; 26(23). PMC: 8658943. DOI: 10.3390/molecules26237342. View

Gamcsik M, Kasibhatla M, Teeter S, Colvin O . Glutathione levels in human tumors. Biomarkers. 2012; 17(8):671-91. PMC: 3608468. DOI: 10.3109/1354750X.2012.715672. View

Vieira L, Castilho M, Ferreira I, Ferreira-Strixino J, Hewitt K, Raniero L . Synthesis and characterization of gold nanostructured Chorin e6 for Photodynamic Therapy. Photodiagnosis Photodyn Ther. 2017; 18:6-11. DOI: 10.1016/j.pdpdt.2016.12.012. View

Narumi A, Rachi R, Yamazaki H, Kawaguchi S, Kikuchi M, Konno H . Maltotriose-Chlorin e6 Conjugate Linked Tetraethyleneglycol as an Advanced Photosensitizer for Photodynamic Therapy. Synthesis and Antitumor Activities against Canine and Mouse Mammary Carcinoma Cells. ACS Omega. 2021; 6(10):7023-7033. PMC: 7970547. DOI: 10.1021/acsomega.0c06316. View

Droge W, Breitkreutz R . Glutathione and immune function. Proc Nutr Soc. 2000; 59(4):595-600. DOI: 10.1017/s0029665100000847. View

Kumari P, Paul M, Bhatt H, Rompicharla S, Sarkar D, Ghosh B . Chlorin e6 Conjugated Methoxy-Poly(Ethylene Glycol)-Poly(D,L-Lactide) Glutathione Sensitive Micelles for Photodynamic Therapy. Pharm Res. 2020; 37(2):18. DOI: 10.1007/s11095-019-2750-0. View

10.

Kim H, Kim M, Jeong Y, Yang H . Redox-Sensitive and Folate-Receptor-Mediated Targeting of Cervical Cancer Cells for Photodynamic Therapy Using Nanophotosensitizers Composed of Chlorin e6-Conjugated β-Cyclodextrin via Diselenide Linkage. Cells. 2021; 10(9). PMC: 8465130. DOI: 10.3390/cells10092190. View

11.

Fu X, Yang Z, Deng T, Chen J, Wen Y, Fu X . A natural polysaccharide mediated MOF-based Ce6 delivery system with improved biological properties for photodynamic therapy. J Mater Chem B. 2020; 8(7):1481-1488. DOI: 10.1039/c9tb02482d. View

12.

Pegaz B, Debefve E, Ballini J, Wagnieres G, Spaniol S, Albrecht V . Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci. 2006; 28(1-2):134-40. DOI: 10.1016/j.ejps.2006.01.008. View

13.

Beack S, Kong W, Jung H, Do I, Han S, Kim H . Photodynamic therapy of melanoma skin cancer using carbon dot - chlorin e6 - hyaluronate conjugate. Acta Biomater. 2015; 26:295-305. DOI: 10.1016/j.actbio.2015.08.027. View

14.

Imran M, Ramzan M, Qureshi A, Khan M, Tariq M . Emerging Applications of Porphyrins and Metalloporphyrins in Biomedicine and Diagnostic Magnetic Resonance Imaging. Biosensors (Basel). 2018; 8(4). PMC: 6316340. DOI: 10.3390/bios8040095. View

15.

Yu L, Wang Z, Mo Z, Zou B, Yang Y, Sun R . Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy. Acta Pharm Sin B. 2021; 11(7):2004-2015. PMC: 8343191. DOI: 10.1016/j.apsb.2021.02.001. View

16.

Sharma S, Mittal D, Verma A, Roy I . Copper-Gallic Acid Nanoscale Metal-Organic Framework for Combined Drug Delivery and Photodynamic Therapy. ACS Appl Bio Mater. 2022; 2(5):2092-2101. DOI: 10.1021/acsabm.9b00116. View

17.

Yang L, He X, Zeng Z, Tang J, Qi D, Ma H . Clickable amino acid tuned self-assembly of a nucleus-selective multi-component nanoplatform for synergistic cancer therapy. Chem Sci. 2021; 12(24):8394-8400. PMC: 8221198. DOI: 10.1039/d1sc01073e. View

18.

Bae I, Kim T, Kim T, Kim D, Kim D, Jo J . Phenethyl Isothiocyanate-Conjugated Chitosan Oligosaccharide Nanophotosensitizers for Photodynamic Treatment of Human Cancer Cells. Int J Mol Sci. 2022; 23(22). PMC: 9693342. DOI: 10.3390/ijms232213802. View

19.

Dougherty T . Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol. 1984; 2(2):83-116. DOI: 10.1016/s1040-8428(84)80016-5. View

20.

Zharova T, Ivannikov S, Tonenkov A, Stranadko E, Semenova L, Smorchkov M . Gonarthritis photodynamic therapy with chlorin e6 derivatives. Photodiagnosis Photodyn Ther. 2016; 15:88-93. DOI: 10.1016/j.pdpdt.2016.06.002. View